Evidence map›Paper›PMID 42720859›Full record

ArticleJournal of community genetics2026

"Will it be enough to be respected?": understanding personal, institutional, and societal harms and benefits of genomics research.

Emerson Dusic, Devin Madden, Isabella E Rios, Arjee Restar, Tiq Milan, Jodie Patterson, David R Pletta, Sima Rabinowitz, Michelle A Ramos, Rodrigo A Aguayo-Romero and 3 more

Abstract read
In one paragraph

Article in Journal of community genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Emerson DusicDepartment of Epidemiology, University of Michigan, University of Michigan School of Public Health, 1415 Washington Heights, Ann Arbor, 48109, MI, USA. edusic@umich.edu.
Devin MaddenInstitute for Health Equity Research, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Isabella E RiosDepartment of Epidemiology, University of Michigan, University of Michigan School of Public Health, 1415 Washington Heights, Ann Arbor, 48109, MI, USA.
Arjee RestarDepartment of Behavioral and Social Sciences, Yale University, New Haven, CT, USA.
Tiq MilanDepartment of Epidemiology, University of Michigan, University of Michigan School of Public Health, 1415 Washington Heights, Ann Arbor, 48109, MI, USA.
Jodie PattersonInstitute for Health Equity Research, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
David R PlettaDepartment of Epidemiology, University of Michigan, University of Michigan School of Public Health, 1415 Washington Heights, Ann Arbor, 48109, MI, USA.
Sima RabinowitzInstitute for Health Equity Research, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Michelle A RamosInstitute for Health Equity Research, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Rodrigo A Aguayo-RomeroThe Institute for Health Research and Policy at Whitman Walker, Washington, DC, USA.
Kellan BakerThe Institute for Health Research and Policy at Whitman Walker, Washington, DC, USA.
Carol R HorowitzInstitute for Health Equity Research, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Sari L ReisnerDepartment of Epidemiology, University of Michigan, University of Michigan School of Public Health, 1415 Washington Heights, Ann Arbor, 48109, MI, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTransgender Identity Genomics Research (TIGR)-research examining potential associations between genetic factors and transgender, nonbinary, and gender diverse (trans) identities-takes place in a complex landscape with significant potential to either benefit or harm trans communities. As public and political scrutiny of trans communities intensifies, the stakes and potential impacts of TIGR are heightened and ethical, legal and social implications must be considered. To better understand how those who would be most affected by TIGR view such research, we explored trans adults' perceptions of TIGR in the current environment and how they perceive TIGR may impact their futures.

methodsUsing a community-based participatory research approach, we partnered with a trans-led Executive Stakeholder Board to conduct in-depth interviews with 31 trans adults in the United States between June-December 2024 and conducted a Reflexive Thematic Analysis.

resultsParticipants (mean age=34 years, range=19-73 years; 61% people of color; 39% nonbinary, 39% transgender women, 22% transgender men) identified possible benefits of TIGR such as personal affirmation, increased social acceptance, and improved access to gender-affirming healthcare. They also expressed concerns about potential harms, including further stigmatization, discrimination, and pathologization of trans identities. While most viewed research in trans communities (including TIGR) as a net positive, some participants felt it less useful compared to addressing more urgent, material challenges trans communities face.

conclusionOur findings underscore that TIGR, like all scientific research, is shaped by the sociopolitical environment. It is imperative that TIGR researchers engage meaningfully and ethically with trans communities to minimize potential harms and center community needs.

Indexed as

GeneticsGenomicsIdentityPublic healthStigmaTransgender

Identifiers

PMID42720859
PMCPMC13562480

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.